Patents/Assignees

JANUX THERAPEUTICS, Inc.

5 patents in portfolio

US12617865utility2026
Activated Antibodies Targeting PSMA and Effector Cell Antigens
0 cites
US12606816utility2026
Inhibitory T Cell Receptor Peptides and Discovery Methods
0 cites
US12433953utility2025
Compositions and Methods Related to Tumor Activated Antibodies Targeting EGFR and Effector Cell Antigens
0 cites
US12161724utility2024
Compositions and Methods Related to Tumor Activated Antibodies Targeting EGFR and Effector Cell Antigens
0 cites
US11555078utility2023
Compositions and Methods Related to Tumor Activated Antibodies Targeting PSMA and Effector Cell Antigens
0 cites